Aptamer Sciences Overview

  • Founded
  • 2011
  • Status
  • Public
  • Employees
  • 31
  • Stock Symbol
  • 291650
Stock Symbol
  • Share Price
  • $20.28
  • (As of Friday Closing)

Aptamer Sciences General Information


Aptamer Sciences Inc is a research and development based bio venture company. The company is focused on the Aptamer Technology Platform for the development of innovative therapeutic and diagnostic platforms. It develops and facilitates drug development and other diagnostic products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Stock Exchange
Primary Office
  • 407 Ho, healthcare Innovation Park
  • 172, Dolma-ro, Bundang-gu
  • Seongnam-si, Gyeonggi-do 13605
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aptamer Sciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.28 $19.76 $17.11 - $34.75 $172M 8.47M 109K -$0.41

Aptamer Sciences Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 134,460 177,894
Revenue 231 194 350 252
EBITDA (2,990) (3,022) (2,370) (5,677)
Net Income (3,188) (3,255) (3,304) (6,682)
Total Assets 32,076 33,855 7,183 9,826
Total Debt 437 106 80 89
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aptamer Sciences Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aptamer Sciences‘s full profile, request access.

Request a free trial

Aptamer Sciences Executive Team (3)

Name Title Board Seat Contact Info
Han Dong II Co-Founder & Chief Executive Officer
Ryu Sung Ho Ph.D Chief Technology Officer
Jang Sung Key Ph.D Chief Scientific Officer
To view Aptamer Sciences’s complete executive team members history, request access »

Aptamer Sciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial